Orthofix Medical
(NASDAQ) OFIX
Orthofix Medical Financials at a Glance
Market Cap
$401.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$825.37M
Net Income (TTM)
-$60.01M
EPS (TTM)
-$1.50
P/E Ratio
-6.62
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$11.51
Volume
1,039,664.872
Open
$10.62
Price
$11.51
Volume
1,039,664.872
Open
$10.62
Previous Close
$11.57
Daily Range
$10.42 - $11.87
52-Week Range
$8.85 - $16.99
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$11.51
Volume
1,039,664.872
Open
$10.62
Previous Close
$11.57
Daily Range
$10.42 - $11.87
52-Week Range
$8.85 - $16.99
Estimated Earnings Date
Aug 4, 2026
OFIX News
Why Orthofix Shares Got Crushed
OFIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Orthofix Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,605
CEO
Massimo Calafiore, MBA
Website
www.orthofix.comHeadquarters
Lewisville, TX 75056, US
OFIX Financials
Key Financial Metrics (TTM)
Gross Margin
69.02%
Operating Margin
-4.03%
Net Income Margin
-7.27%
Return on Equity
-13.44%
Return on Capital
-10.08%
Return on Assets
-6.77%
Earnings Yield
-15.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$401.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
40.42M
Volume
1.04M
Avg. Volume
392.24K
Financials (TTM)
Gross Profit
$569.63M
Operating Income
-$33.28M
EBITDA
$94.51M
Operating Cash Flow
$34.91M
Capital Expenditure
-$38.54M
Free Cash Flow
-$3.63M
Cash & ST Invst.
$120.28M
Total Debt
$234.39M
Orthofix Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$196.71M
+1.6%
Gross Profit
$139.55M
+14.7%
Gross Margin
70.94%
N/A
Market Cap
$401.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$248.63K
N/A
Employees
1,616
N/A
Net Income
-$20.91M
+60.6%
EBITDA
-$1.68M
+86.0%
Quarterly Fundamentals
Total Cash
$120.28M
+107.5%
Total Debt
$234.39M
+21.6%
Accounts Receivable
$137.78M
+4.5%
Inventory
$177.82M
+1.9%
Long Term Debt
$234.27M
+24.8%
Short Term Debt
$115.00K
-97.7%
Return on Assets
-6.77%
N/A
Return on Invested Capital
-4.59%
N/A
Free Cash Flow
-$28.27M
-12.5%
Operating Cash Flow
-$17.61M
+4.2%